11/18
08:50 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
11/18
08:50 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
11/7
10:58 am
crl
Rating for CRL
Low
Report
Rating for CRL
11/7
09:03 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at CLSA from an "underperform" rating to a "hold" rating. They now have a $205.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at CLSA from an "underperform" rating to a "hold" rating. They now have a $205.00 price target on the stock.
11/7
09:03 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at CLSA from an "underperform" rating to a "hold" rating. They now have a $205.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at CLSA from an "underperform" rating to a "hold" rating. They now have a $205.00 price target on the stock.
11/7
08:44 am
crl
Rating for CRL
Low
Report
Rating for CRL
11/6
06:32 pm
crl
Charles River upgraded to Hold from Underperform at CLSA
Low
Report
Charles River upgraded to Hold from Underperform at CLSA
11/6
06:32 pm
crl
Charles River upgraded to Hold from Underperform at CLSA
Low
Report
Charles River upgraded to Hold from Underperform at CLSA
10/23
07:35 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at CLSA. They set an "underperform" rating and a $167.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at CLSA. They set an "underperform" rating and a $167.00 price target on the stock.
10/23
07:35 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at CLSA. They set an "underperform" rating and a $167.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at CLSA. They set an "underperform" rating and a $167.00 price target on the stock.
10/23
06:44 am
crl
Rating for CRL
Low
Report
Rating for CRL
10/23
06:44 am
crl
Rating for CRL
Low
Report
Rating for CRL
10/23
06:17 am
crl
Charles River initiated with bearish view at CLSA
Low
Report
Charles River initiated with bearish view at CLSA
10/23
06:17 am
crl
Charles River initiated with bearish view at CLSA
Low
Report
Charles River initiated with bearish view at CLSA
10/7
08:10 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $190.00 price target on the stock, down previously from $225.00.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $190.00 price target on the stock, down previously from $225.00.
10/7
08:10 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $190.00 price target on the stock, down previously from $225.00.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $190.00 price target on the stock, down previously from $225.00.
10/7
07:39 am
crl
Rating for CRL
Low
Report
Rating for CRL
10/1
09:28 am
crl
Rating for CRL
Low
Report
Rating for CRL
10/1
09:28 am
crl
Rating for CRL
Low
Report
Rating for CRL
10/1
07:36 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $175.00 price target on the stock, down previously from $215.00.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $175.00 price target on the stock, down previously from $215.00.